Schmaljohn et al., 1999 - Google Patents
Evaluation of tick-borne encephalitis DNA vaccines in monkeysSchmaljohn et al., 1999
View PDF- Document ID
- 3226827355111848857
- Author
- Schmaljohn C
- Custer D
- VanderZanden L
- Spik K
- Rossi C
- Bray M
- Publication year
- Publication venue
- Virology
External Links
Snippet
Tick-borne encephalitis is usually caused by infection with one of two flaviviruses: Russian spring summer encephalitis virus (RSSEV) or Central European encephalitis virus (CEEV). We previously demonstrated that gene gun inoculation of mice with naked DNA vaccines …
- 241000282693 Cercopithecidae 0 title abstract description 102
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schmaljohn et al. | Evaluation of tick-borne encephalitis DNA vaccines in monkeys | |
| Porter et al. | Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses | |
| Mahon et al. | Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. | |
| Kwilas et al. | A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates | |
| Li et al. | An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs | |
| US11478543B1 (en) | Coronavirus disease (COVID-19) vaccine | |
| CN113164586A (en) | Immune composition and preparation method and application thereof | |
| WO2000011140A1 (en) | Methods of augmenting mucosal immunity through systemic priming and mucosal boosting | |
| Bhardwaj et al. | Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus | |
| CN118217386B (en) | A porcine reproductive and respiratory syndrome mRNA vaccine | |
| US5718902A (en) | Double recombinant vaccinia virus vaccines | |
| US7217812B2 (en) | Extraneous DNA sequence that facilitates hantavirus gene expression | |
| US20070026015A1 (en) | Method | |
| Farnudian-Habibi et al. | Review on approved and inprogress COVID-19 vaccines | |
| Nass et al. | Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins | |
| CN118159288A (en) | Virus-like particle vaccines for coronavirus | |
| US8183358B2 (en) | Puumala virus full-length M segment-based DNA vaccines | |
| Toussaint et al. | Genetic immunisation of cattle against bovine herpesvirus 1: glycoprotein gD confers higher protection than glycoprotein gC or tegument protein VP8 | |
| US20230149528A1 (en) | Development of mosaic vaccines against foot and mouth disease virus serotype o | |
| EP1146900B1 (en) | Dna vaccines against hantavirus infections | |
| Burnette | Recombinant subunit vaccines | |
| US8852598B2 (en) | Puumala virus full-length M segment-based DNA vaccines | |
| Selvam et al. | COVID-19 vaccines and the efficacy of currently available vaccines against COVID-19 variants | |
| CA3184406A1 (en) | A dna plasmid sars-coronavirus-2/covid-19 vaccine | |
| Choudary et al. | Enhanced immune response of DNA vaccine (VP1-pCDNA) adsorbed on cationic PLG for foot and mouth disease in guinea pigs |